Yes, maybe more, here's my more detailed opinion.
https://docs.google.com/spreadsheets/d/1-RfT2izeKSqHLt9jYotj0_nt_mAQt8ZYEf59lkUyojE/edit?usp=sharing
I've posted it a few times now. Ultimately depends if you think the products will be a success. Enterprise dementia product is already showing early signs of success here in Australia, and is kicking off in NZ and the UK. I think rollout may accelerate, as they've likely gone through any teething issues here in the initial stages. I also think dementia direct to carer will be successful. The children's app, well if that can grab even a small %age of the target market PCK will be a behemoth, I personally think that's wishful thinking but not an impossibility.
PE, depends on many factors whether or not PE 20 would be reasonable. For a stock showing consistent growth, and a good revenue model, PE 20 is decent buying IMO.
https://www.investopedia.com/terms/p/price-earningsratio.asp
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-11162
-
-
- There are more pages in this discussion • 9,251 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.002(7.14%) |
Mkt cap ! $49.07M |
Open | High | Low | Value | Volume |
2.8¢ | 3.0¢ | 2.8¢ | $9.306K | 318.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 43275 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 1255935 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43275 | 0.029 |
5 | 1354635 | 0.028 |
8 | 1053639 | 0.027 |
3 | 365422 | 0.026 |
3 | 3000000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 1255935 | 2 |
0.032 | 24900 | 1 |
0.033 | 410208 | 3 |
0.034 | 5874 | 1 |
0.035 | 40000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
PCK (ASX) Chart |